Skip to main content
. 2017 Feb 15;8(15):24337–24353. doi: 10.18632/oncotarget.15363

Figure 8. Particle size distribution determined using DLS, in solutions of BSA-HA conjugates (black dashed line), non-encapsulated IA C-1375 (80 μM, gray) and of C-1375 loaded BSA-HA NPs (solid black line) at the same concentrations of the respective components.

Figure 8

The molar ratio of C-1375:BSA-HA conjugates was 2:1.